Kensai Health delivers senior-led regulatory medical writing, active biostatistical oversight, pharmacovigilance safety documents, and evidence synthesis. We turn complex clinical trial data into submission-grade regulatory narratives with zero bureaucracy.
Large CROs pitch seasoned leaders but delegate actual writing to junior, revolving staff. Kensai Health eliminates turnover, bridges data-writing silos, and ensures first-time-right regulatory quality.
Your clinical program is authored and guided directly by senior clinical specialists with over two decades of global regulatory submission experience—not delegated to junior coordinators.
Most medical writers wait passively for tables. We review Statistical Analysis Plans (SAPs) and Mock TLF shells upstream, participate in dry runs, and bridge the gap between programmers and clinical teams.
Clinical writing is 30% typing and 70% alignment. We steer structured Comment Resolution Meetings (CRMs), resolve conflicting reviewer input, and engage Principal Investigators (PIs) and KOLs smoothly.
From early trial protocol design to global registrational dossiers, pharmacovigilance safety documents, and high-impact medical publications.
Submission-grade Clinical Study Reports (ICH E3), Phase I–IV Protocols, Investigator's Brochures (IBs), eCTD Modules 2.4–2.7, 4 & 5 (ISS/ISE), and EU MDR Medical Device CERs/CEPs.
View Regulatory Services →Upstream SAP & Mock TLF co-design, biostatistics & Data Management vendor oversight, pre-DBL blind data reviews, and conversion of complex SAS outputs into clear regulatory narratives.
View Statistical Synergy →High-volume patient safety narratives (SAEs, AESIs, deaths), Development Safety Update Reports (DSURs), PSURs, PBRERs, and safety database software familiarity (Argus Safety).
View Safety Documents →High-impact scientific posters and abstracts for international congresses (ASCO, ESMO, EHA), executive slide decks for advisory boards and product launches, and visual aids.
View Medical Communications →Peer-reviewed manuscripts for indexed Q1/Q2 journals (ICMJE/GPP4), PRISMA-compliant Systematic Literature Reviews (SLR), Meta-Analyses with forest plots, and advanced quantitative research synthesis.
View Evidence Synthesis →Kensai Health was founded to deliver what large multinational agencies cannot: dedicated, senior-level scientific authorship and meticulous regulatory precision without the overhead of massive corporate bureaucracy.
Complex Data. Clear Insights. Regulatory Precision.
"Every document that leaves our desk is audit-ready, scientifically sound, and submission-grade."